Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency, Nature Communications, vol.104, p.8940, 2015. ,
DOI : 10.1038/ncomms9940
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine, Genome Biology, vol.10, issue.8 ,
DOI : 10.1186/s13059-014-0453-8
Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells Tumour evolution inferred by single-cell sequencing, Genome Biol. Nature, vol.16472, issue.7341, pp.90-94, 2011. ,
Deciphering intratumor heterogeneity using cancer genome analysis, Human Genetics, vol.346, issue.6, pp.635-677, 2016. ,
DOI : 10.1007/s00439-016-1670-x
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem cells international, vol.2016, p.3631764, 2016. ,
Notch Activation as a Driver of Osteogenic Sarcoma, Cancer Cell, vol.26, issue.3, pp.390-401, 2014. ,
DOI : 10.1016/j.ccr.2014.07.023
Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression, Oncogene, vol.56, issue.40, pp.4857-66, 2014. ,
DOI : 10.1111/j.1048-891x.2004.014314.x
Perspectives on cancer stem cells in osteosarcoma, Cancer Letters, vol.338, issue.1, pp.158-67, 2013. ,
DOI : 10.1016/j.canlet.2012.05.028
Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report, Journal of Medical Case Reports, vol.12, issue.2, p.9298, 2009. ,
DOI : 10.1200/JCO.20.3.776
Cancer Stem Cells--Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer Research, vol.66, issue.19, pp.9339-9383, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-3126
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas, Oncogene, vol.54, issue.18, pp.312270-82, 2012. ,
DOI : 10.1101/gad.9.21.2635
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells, Nature Communications, vol.168, p.6411, 2015. ,
DOI : 10.1038/ncomms7411
Mechanisms of stem cell self-renewal, Annu Rev Cell Dev Biol, vol.25, pp.377-406, 2009. ,
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer, Oncotarget, 2016. ,
DOI : 10.18632/oncotarget.9251
Bone sarcomas: pathogenesis and new therapeutic approaches, IBMS BoneKEy, vol.17, issue.9, pp.402-416, 2011. ,
DOI : 10.1138/20110531
Methods for Cancer Stem Cell Detection and Isolation, Methods Mol Biol, vol.879, pp.513-542, 2012. ,
DOI : 10.1007/978-1-61779-815-3_32
Cancer stem cell definitions and terminology: the devil is in the details, Nature Reviews Cancer, vol.2, issue.11, pp.767-75, 2012. ,
DOI : 10.1038/nrc3368
Tumor initiating potential of side population cells in human gastric cancer, International journal of oncology, vol.34, issue.5, pp.1201-1208, 2009. ,
The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer research, pp.5658-68, 2008. ,
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization, The FASEB Journal, vol.27, issue.1, pp.13-24, 2013. ,
DOI : 10.1096/fj.12-218222
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas, British Journal of Cancer, vol.48, issue.8, pp.1425-1457, 2009. ,
DOI : 10.1073/pnas.192276999
Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells, Cancer Science, vol.70, issue.10, pp.1774-81, 2011. ,
DOI : 10.1111/j.1349-7006.2011.02028.x
URL : http://doi.org/10.1111/j.1349-7006.2011.02028.x
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance, Oncology Reports, vol.24, issue.2, pp.501-506, 2010. ,
DOI : 10.3892/or_00000885
ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone, Journal of Cancer Therapy, vol.05, issue.04, pp.331-339, 2014. ,
DOI : 10.4236/jct.2014.54040
Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity, International Journal of Cancer, vol.110, issue.Suppl 1, pp.294-303, 2011. ,
DOI : 10.1002/ijc.25331
Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours, PLoS ONE, vol.89, issue.104, p.3469, 2008. ,
DOI : 10.1371/journal.pone.0003469.t001
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo, The FASEB Journal, vol.25, issue.6, pp.2022-2052, 2011. ,
DOI : 10.1096/fj.10-179036
CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study. Experimental and therapeutic medicine, pp.435-476, 2012. ,
CD133 expression in osteosarcoma and derivation of CD133(+) cells. Molecular medicine reports, pp.577-84, 2013. ,
Clinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating Cells, STEM CELLS, vol.65, issue.4, pp.959-73, 2014. ,
DOI : 10.1002/stem.1618
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer research, pp.4602-4614, 2010. ,
DOI : 10.1158/0008-5472.can-09-3463
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139225
CD271+ Osteosarcoma Cells Display Stem-Like Properties, PLoS ONE, vol.312, issue.6, p.98549, 2014. ,
DOI : 10.1371/journal.pone.0098549.t001
URL : http://doi.org/10.1371/journal.pone.0098549
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis, Neoplasia, vol.7, issue.11, pp.967-76, 2005. ,
DOI : 10.1593/neo.05394
Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines, International journal of oncology, vol.34, issue.5, pp.1381-1387, 2009. ,
Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line, BMC Cancer, vol.391, issue.1, p.139, 2012. ,
DOI : 10.1016/j.bbrc.2009.12.020
Osteosarcoma Stem Cells Have Active Wnt/beta-catenin and Overexpress SOX2 and KLF4, Journal of cellular physiology, vol.231, issue.4, pp.876-86, 2016. ,
Transforming Growth Factor ??1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma, STEM CELLS, vol.205, issue.162, pp.433-479, 2013. ,
DOI : 10.1002/stem.1298
TGF-?? Signaling in Bone Remodeling and Osteosarcoma Progression, Journal of Clinical Medicine, vol.5, issue.11, 2016. ,
DOI : 10.3390/jcm5110096
URL : http://doi.org/10.3390/jcm5110096
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1, Oncogene, vol.31, issue.2, 2016. ,
DOI : 10.1007/s11060-013-1061-2
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity, Oncotarget, vol.4, issue.12, pp.2326-2364, 2013. ,
DOI : 10.18632/oncotarget.1554
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/beta-catenin signaling. Cancer letters, pp.286-95, 2016. ,
Enrichment of osteosarcoma stem cells by chemotherapy, Chinese Journal of Cancer, vol.30, issue.6, pp.426-458, 2011. ,
DOI : 10.5732/cjc.011.10127
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling, Oncogene, vol.50, issue.28, pp.3923-3957, 2008. ,
DOI : 10.1038/onc.2008.38
Cisplatin selects for stem-like cells in osteosarcoma by activating notch signaling, Oncotarget, 2016. ,
DOI : 10.18632/oncotarget.8849
High CD49f expression is associated with osteosarcoma tumor progression: a study using patientderived primary cell cultures. Cancer medicine, pp.796-811, 2014. ,